DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 57734-70-0, Bicarphen, Bicarfen, Quinuclidin-3-yldi-o-tolylmethanol hydrochloride, 1-azabicyclo[2.2.2]oct-3-yl[bis(2-methylphenyl)]methanol hydrochloride, 305t85j01y

Molecular Formula

C₂₂H₂₈ClNO

Molecular Weight

357.9 g/mol

InChI Key

WCYWFJOJKZCSAJ-UHFFFAOYSA-N

FDA UNII

305T85J01Y

1 2D Structure

Sequifenadine Hydrochloride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

1-azabicyclo[2.2.2]octan-3-yl-bis(2-methylphenyl)methanol;hydrochloride

2.1.2 InChI

InChI=1S/C22H27NO.ClH/c1-16-7-3-5-9-19(16)22(24,20-10-6-4-8-17(20)2)21-15-23-13-11-18(21)12-14-23;/h3-10,18,21,24H,11-15H2,1-2H3;1H

2.1.3 InChI Key

WCYWFJOJKZCSAJ-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC1=CC=CC=C1C(C2CN3CCC2CC3)(C4=CC=CC=C4C)O.Cl

2.2 Other Identifiers

2.2.1 UNII

305T85J01Y

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Bicarfen

2. Bicarphen

3. Bicarphene

4. Bicarphene Hydrochloride

5. Bikarfen

6. Quinuclidinyl-3-di(o-tolyl)carbinol

7. Quinuclidyl-3-di-o-tolylcarbinol

2.3.2 Depositor-Supplied Synonyms

1. 57734-70-0

2. Bicarphen

3. Bicarfen

4. Quinuclidin-3-yldi-o-tolylmethanol Hydrochloride

5. 1-azabicyclo[2.2.2]oct-3-yl[bis(2-methylphenyl)]methanol Hydrochloride

6. 305t85j01y

7. Bikarfen

8. 1-azabicyclo(2.2.2)octane-3-methanol, Alpha,alpha-bis(2-methylphenyl)-, Hydrochloride

9. 1-azabicyclo[2.2.2]oct-3-yl[bis(2-methylphenyl)]-methanol Hydrochloride

10. Unii-305t85j01y

11. (quinuclidyl-3)-di-(o-tolyl)carbinol Hydrochloride

12. Mls006010882

13. Schembl11764873

14. Dtxsid30973319

15. Mfcd17676104

16. Akos005110994

17. Alpha,alpha-bis(2-methylphenyl)-1-azabicyclo(2.2.2)octane-3-methanol Hydrochloride

18. Smr004701799

19. Sequifenadine Hydrochloride [who-dd]

20. Ft-0682670

21. Quinuclidin-3-yldi-o-tolylmethanolhydrochloride

22. A923088

23. 1-azabicyclo[2.2.2]octan-3-yl-bis(2-methylphenyl)methanol;hydrochloride

24. (1-azabicyclo[2.2.2]octan-3-yl)bis(2-methylphenyl)methanol--hydrogen Chloride (1/1)

25. 1-azabicyclo(2.2.2)octane-3-methanol, .alpha.,.alpha.-bis(2-methylphenyl)-, Hydrochloride (1:1)

2.4 Create Date

2011-02-22

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₈ClNO
Molecular Weight	357.9 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	3
Exact Mass	357.1859422 g/mol
Monoisotopic Mass	357.1859422 g/mol
Topological Polar Surface Area	23.5 Å²
Heavy Atom Count	25
Formal Charge	0
Complexity	406
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

ABOUT THIS PAGE

Find Sequifenadine Hydrochloride manufacturers, exporters & distributors on PharmaCompass

Sequifenadine Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?